Lupin recalls
Lupin has 4 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 29 Nov 2017. The most frequent reason is manufacturing (cgmp) deviations.
Total recalls4since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 29 Nov 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 25%Class III 3 75%
Why lupin is recalled
Product types
Brands
By year
All lupin recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Pravastatin Sodium USP, tablets, 40 mg recalled by LupinPravastatin Sodium | Lupin | Other | Nationwide |
| Drug | CLASS III | Escitalopram Tablets USP 20 mg recalled by LupinEscitalopram | Lupin | Other | Nationwide |
| Drug | CLASS III | Amlodipine Besylate Tablets USP, 10mg recalled by LupinAmlodipine Besylate | Lupin | Manufacturing (CGMP) Deviations | |
| Drug | CLASS III | Amlodipine Besylate Tablets USP, 2.5mg recalled by LupinAmlodipine Besylate | Lupin | Manufacturing (CGMP) Deviations |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.